What's new

On 29 June 2018, the ARPANSA CEO issued a Direction to ANSTO to initiate an independent safety review following a series of events with safety implications at the ANSTO Health (now Health Products) facility. ARPANSA has been monitoring progress against the implementation plan and is generally satisfied with the actions taken to date.

The Australian Nuclear Science and Technology Organisation (ANSTO), one of ARPANSA’s major licence holders, has submitted an application to increase temporary storage of radioactive waste at their Lucas Heights site. ARPANSA will host a consultation forum on Wednesday 13 October.

ARPANSA has launched a new research framework to facilitate research of electromagnetic energy exposures and health.

The International Commission on Radiological Protection (ICRP) has commenced a review of its System of Radiological Protection. The System provides recommendations for protection of people and the environment from the harmful effects of ionising radiation.

ARPANSA is pleased to be collaborating with Monash University to support a PhD opportunity to investigate injuries from cosmetic use of non-ionising radiation.

ARPANSA is proud to announce that our Chief Radiation Health Scientist and Deputy CEO, Dr Gillian Hirth, has been appointed to the Main Commission of the International Commission on Radiological Protection (ICRP) for the term 2021-2025.

ARPANSA works with international bodies to share knowledge and develop best practice radiation protection and nuclear safety through regulation.

International academic journal, Radiation Protection Dosimetry, has announced that ARPANSA’s 2017 research paper ‘Exposure to Radiofrequency Electromagnetic Field from Wi-fi in Australian schools’, is one of the five most-read articles in the journal’s history.